Testing a new bladder cancer treatment delivered directly into the bladder

This is an early-stage (Phase I) clinical trial testing a new treatment called SHR-2005 for bladder cancer. The medication is delivered directly into your bladder through instillation, which means it's placed in your bladder rather than taken by mouth or injection. Researchers want to learn if this treatment is safe, well-tolerated, and effective for people with intermediate or high-risk non-muscle invasive bladder cancer.

Current treatment options for non-muscle invasive bladder cancer have limitations, and doctors are seeking new ways to deliver medication directly to cancer cells in the bladder. This trial is testing whether this medication might offer a better treatment option for patients who have a higher risk of cancer recurrence or progression.